Factor Xa (FXa) is a serine protease which plays a critical role in the coagulation cascade, serving as the point of convergence of intrinsic and extrinsic pathways.
Most nonpeptide FXa inhibitors reported in the literature are dibasic compounds. Nagahara et al. 15, 16) have reported the synthesis and evaluation of a series of bis(amidino)-derivatives, and through investigation, DX-9065a (1) [17] [18] [19] [20] [21] was found to be a selective FXa inhibitor. Further, YM-60828 (2), [22] [23] [24] [25] [26] [27] which is closely related to 1 in terms of structure, was found to have a more potent inhibitory effect on FXa.
On the other hand, as described in the preceding paper, 1) we have synthesized M55113 (3) as a potent inhibitor of FXa (IC 50 ϭ0.06 mM) with high selectivity for FXa over trypsin and thrombin. Compared with the structure of compound 3, the features of compound 1 and compound 2 include a functional acid group in the linker part of the molecule. According to the Xray structure of the complex of compound 1 in des-GlaFXa, 28) it is clear that the nitrogen atom of Gln-192 forms a weak hydrogen bond with the acid function of compound 1.
In order to obtain a compound which has powerful inhibitory activity on FXa, it is necessary to introduce a functional group into the position at which compound 3 and Gln-192 of FXa protein are expected to form a hydrogen bond.
In this paper, we wish to report the continuing search for potent compounds that have a substituent at the piperazine and piperidine rings of compound 3. Thus, the structure-activity relationships of compound 3 derivatives were examined.
Chemistry
A key intermediate 7 was prepared from glycine ethyl ester hydrochloride, as illustrated in Chart 1. The compound 5, obtained by the reaction of glycine ethyl ester hydrochloride (4) with bromoacetaldehyde diethyl acetal in the presence of cesium carbonate (Cs 2 CO 3 ) 29, 30) and sodium iodide, was treated with 6-chloro-2-naphthalenesulfonyl chloride under basic conditions, and the resulting sulfonamide 6 was hydrolyzed with aqueous trifluoroacetic acid (TFA) to give the formyl compound 7.
Synthetic routes of compounds 12 and 17 are shown in Chart 2. Compound 9 was prepared by protection of the primary amino group with di-tert-butyl dicarbonate (Boc 2 O) and subsequent debenzylation of a secondary amino group with H 2 over Pd/C. Condensation of 9 with 4-chloropyridine 1-oxide under basic conditions gave the 4-piperidinopyridine 1-oxide derivative 10. Hydrogenolysis of 10 over Raney Ni 31) in methanol (MeOH), followed by treatment with HClMeOH, yielded compound 11. The final compound 12 was obtained smoothly by reductive condensation of 11 with the intermediate 7. 32) Reaction conditions in the preparation of compound 17 from compound 13 33) were not much different from the conversion of 8 to 12.
Synthesis of 4-substituted piperidine derivatives containing another functional group (compound 18-20) in place of the hydroxyl group in 12 was accomplished as shown in Chart 3.
Swern oxidation 34) of 17, followed by condensation of the resulting aldehyde with hydroxylamine under traditional con-ditions, afforded 4-(hydroxyiminomethy)piperidine (18) . When the aldehyde was treated with NaClO 2 and trimethylsilyldiazomethane, the carboxylic acid (19) and the corresponding methyl ester (20) were obtained in good yields, respectively.
Synthesis of piperazine derivatives containing a functional carbon group on the 6-position of the piperazine ring was accomplished according to the route shown in Chart 4.
The crude carbaldehyde (22) which was obtained by Swern oxidation of 1-(4-pyridinyl)-4-piperidinemethanol 35) (21) was treated with 3-(tert-butoxycarbonylamino)alanine ethyl ester 36) under reductive conditions to give compound 23. Compound 24 was yielded by the acylation of 23 with chloroacetyl chloride in the presence of triethylborane (Et 3 B) under basic conditions, followed by deprotection with HCl-EtOH and then ring cyclization with Et 3 N in DMF.
The sulfonylation of compound 24 with 6-chloro-2-naphthalenesulfonyl chloride gave compound 25, and the corresponding carboxylic acid (26) was obtained by the hydrolysis of 24 with aqueous NaOH. Compound 27 was prepared by heating 26 with methanolic ammonia in a sealed tube. Compound 28 was yielded by the reduction of compound 25 with lithium borohydride. Compound 29 was obtained by the methylation of compound 28 with dimethyl sulfate. Compound 28 was treated with phthalimide by Mitsunobu reaction, and with hydrazine, successively, to give compound 30. The oxidation of 28, followed by condensation of the resulting aldehyde with hydroxylamine under traditional conditions, afforded 6-(hydroxyiminomethyl)-2-piperazinone (31).
Results and Discussion
The FXa inhibitory activity of the compounds synthesized above was measured by a method similar to that described in the preceding paper.
1) The results are listed in Tables 1 and 2 . It is conceivable that the activity of compounds increases when a substituent having hydrogen bond donating ability is introduced into the molecule. In fact, 12 and 17 showed slightly higher activity than lead compound 3, as listed in Table 1 . The carboxylic acid (19) , however, showed very low activity (1/10), contrary to our anticipation, while the activity of the corresponding ester (20) is about same degree as that of the original compound 3.
As described above, the substituent effect at the 4-position of the piperidine ring on the activity is indistinct at present. Accordingly, no further compounds with a substituent at the 4-position were synthesized.
Next, the activity of the compounds containing a substituent at the 6-position of the piperazine moiety was examined. As summarized in Table 2 , all the compounds in this series showed higher inhibitory activity than the lead compound 3.
When any substituent in which especially a hydrogen bond is possible was introduced into the molecule, the FXa inhibitory activity of the compounds increased. Especially, the activity of compound 26 was six times more powerful than the lead compound 3.
At the final stage of the present investigation, the comparison of stereo isomers (R,S) of 6-substituted 2-piperazinones on the inhibitory activity was carried out.
The activity of stereo isomers (R and S) of 25 was examined; (R)-isomer (32, 0.017 mM) had more powerful activity than (S)-isomer (33, 0.070 mM). Then the (R and S)-isomer of free carboxylic acid (26) was obtained by the hydrolysis of 32 and 33 under acidic conditions. The activity of the stereoisomers (R and S) of 26 was examined; (R)-isomer (34, 0.006 mM) had more powerful activity than (S)-isomer (35, 0.079 mM).
The activity of this compound (34: M55551) is ten times more powerful than the lead compound (3: M55113).
It should also be mentioned that M55551 (34) showed clear selectivity for FXa over related serine proteases; in particular, the compound is 16000-fold more selective for FXa than for thrombin and trypsin, as shown in Table 3 .
On the basis of these results described in the preceding and present papers, M55551 (34) is evaluated to be the best compound among all the derivatives in a series of 1-arylsulfonyl-3-piperazinones, not only in FXa inhibition activity but also in selectivity between FXa and other serine proteases.
Crystallization of a complex of M55551 with FXa was attempted in order to determine whether the carboxylic acid of M55551 and Gln-192 of FXa protein form a hydrogen bond.
Experimental
Nuclear magnetic resonance (NMR) spectra were taken with JEOL JNM-EX270 FT-NMR (JEOL, Ltd.) or JEOL JNM-LA300 (JEOL, Ltd.) in CDCl 3 or dimethyl sulfoxide-d 6 (DMSO-d 6 ) using tetramethylsilane as the internal reference. Data measured by JEOL JNM-LA300 are marked with an asterisk. The following abbreviations were used: sϭsinglet, dϭdoublet, ddϭdou-ble doublet, dtϭdouble triplet, tϭtriplet, qϭquartet, mϭmultiplet and brϭbroad. High-resolution mass spectra (HR-MS) were taken with JEOL JMS-GCMATE (JEOL, Ltd.). Optical rotations were determined in the indicated solvents on a JASCO DIP-1000 digital polarimeter (JASCO Corporation). Elemental analysis was performed on a CHNS-O EA1108 elemental analyzer (Carlo Erba Instruments).
Measurement of Factor Xa, Thrombin and Trypsin Inhibition The enzyme solution was mixed with a test compound dissolved at various concentrations in dimethyl sulfoxide (DMSO). A synthetic substrate was added and incubated in a 20 mM Tris-HCl buffer (pH 7.5) containing 0.13 M NaCl at 37°C. The absorbance at 405 nm was measured continuously. The following enzymes and substrates were used: human factor Xa (Enzyme Research Laboratories, Inc., 0.019 U/ml) and S-2222 (Chromogenix AB, 0.4 mM); human thrombin (Sigma Co., 0.09 U/ml) and S-2238 (Chromogenix AB, 0.2 mM); human trypsin (Athens Research and Technology, Inc., 15 ng/ml) and S-2222 (Chromogenix AB, 0.4 mM). To calculate the inhibitory activity of the test compound, the initial reaction velocity was compared with the value of a control containing no test compound. The inhibitory activity of the test compound was expressed as IC 50 .
N-(2,2-Diethoxyethyl)glycine Ethyl Ester (5) To the suspension of glycine ethyl ester hydrochloride 4 (1.00 g, 7.2 mmol) and bromoacetaldehyde diethyl acetal (1.08 ml, 7.0 mmol) in N,N-dimethylformamide (DMF) (30 ml), cesium carbonate (4.67 g, 14.4 mmol) and sodium iodide (107 mg, 0.7 mmol) were added. The reaction mixture was stirred for 4 h at 100°C. After cooling, the reaction mixture was acidified with 1 N aqueous HCl to pH 2 and was washed with AcOEt. Then the aqueous layer was made basic with 1 N aqueous NaOH to pH 11, and was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 (20 ml) , triethylamine (Et 3 N) (336 ml, 2.4 mmol) and 6-chloro-2-naphtalenesulfonyl chloride (600 mg, 2.3 mmol) were added at 0°C. The reaction mixture was stirred at ambient temperature overnight. Then brine was added to the reaction mixture and the reaction mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; n-hexane : AcOEtϭ20 : 1-4 : 1) to give compound 6 (750 mg, 74%). N-[(6-Chloro-2-naphthalenyl)sulfonyl]-N-(2-oxoethyl)glycine Ethyl Ester (7) To a mixture of trifluoroacetic acid (5 ml), CHCl 3 (1.5 ml) and H 2 O (2.5 ml), the solution of compound 6 (560 mg, 1.3 mmol) in CHCl 3 (1 ml) was added with vigorous stirring at 0°C. After 1.5 h, the reaction mixture was made basic with saturated sodium hydrogencarbonate (NaHCO 3 ) aq. to pH 8, and was then extracted with diethyl ether (Et 2 O). The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; n-hexane : AcOEtϭ5 : 1-2 : 1) to give compound 7 (240 mg, 51%). [(4-Hydroxy-4-piperidinyl)methyl]carbamic Acid 1,1-Dimethylethyl Ester (9) To a solution of 4-(aminomethyl)-1-(phenylmethyl)-4-piperidinol (8) (7.5 g, 34 mmol) in 1,4-dioxane-H 2 O (66-34 ml), 1 N aqueous NaOH (34 ml) and Boc 2 O (8.16 g, 37.4 mmol) were added, successively. The reaction mixture was stirred at 60°C for 4 h. After cooling, the reaction mixture was extracted with EtOAc. The organic layer was washed with water and brine, dried over Na 2 SO 4 6 mmol) and 10% Pd-C (800 mg) in MeOH (300 ml), ammonium formate (4.84 g, 76.8 mmol) was added, and the reaction mixture was refluxed for 2 h. Then the catalyst was removed by filtration and the filtrate was condensed to afford 9 (6.03 g, 99%) as a colorless crystal. 8 mmol) was added, and the reaction mixture was refluxed for 6 h. After cooling, water was added to the reaction mixture and the reaction mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 Cl 2 : MeOHϭ9 : 1-4 : 1) to give compound 10 (1.03 g, 37%). 
4-(Aminomethyl)-1-(4-pyridinyl)-4-piperidinol Hydrochloride (11)
To a solution of compound 10 (300 mg, 0.93 mmol) in MeOH (3 ml), RaneyNi (catalytic amount) was added, and the reaction mixture was stirred in an atmosphere of hydrogen for 3.5 h at ambient temperature. Then the catalyst was removed by filtration and the filtrate was condensed. The residue was purified by silica gel column chromatography (eluents; CH 2 [[4-Hydroxy-1-(4-pyridinyl)-4-piperidinyl]methyl]carbamic acid 1,1-dimethylethyl ester (175 mg, 0.57 mmol) was dissolved in 10% HCl-MeOH (2 ml), and the reaction mixture was stirred for 2 h at ambient temperature. The solvent was removed under reduced pressure. The residue was triturated with Et 2 O to give compound 11 (160 mg, 89% 
4-[(6-Chloro-2-naphthalenyl)sulfonyl]-1-[[4-hydroxy-1-(4-pyridinyl)-4-piperidinyl]methyl]piperazinone (12)
Acetic acid (0.02 ml) was added to a suspension of compound 7 (58.4 mg, 0.16 mmol) and compound 11 (50 mg, 0.16 mmol) in CH 2 Cl 2 (3 ml) at 0°C. The reaction mixture was stirred for 1 h at ambient temperature. Then sodium triacetoxyborohydride (NaBH(OAc) 3 ) (67 mg, 0.32 mmol) was added to the reaction mixture at 0°C, and the reaction mixture was stirred at ambient temperature overnight. Then the reaction mixture was made basic with 1 N aqueous NaOH to pH 9, and was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 (10-5ml) , 10% Pd-C (80 mg) was added, and the reaction mixture was stirred in an atmosphere of hydrogen for 2 d at ambient temperature. Then the catalyst was removed by filtration and the filtrate was condensed. The residue was purified by silica gel column chromatography (CH 2 Cl 2 : MeOHϭ20 : 1-5 : 1) to give 14 (230 mg, 39%) as a colorless crystal. [
[4-(Hydroxymethyl)-1-(1-oxido-4-pyridinyl)-4-piperidinyl]methyl]-carbamic Acid 1,1-Dimethylethyl Ester (15)
To the suspension of compound 14 (1.88 g, 7.7 mmol) and 4-chloropyridine 1-oxide (1.00 g, 7.7 mmol) in isoamylalcohol (15 ml), NaHCO 3 (1.55 g, 18.5 mmol) was added, and reaction mixture was refluxed for 2 h. After cooling, water was added to the reaction mixture, and the reaction mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 Cl 2 : MeOHϭ20 : 1-13 : 2) to give compound 15 (1.11 g, 43%). was added to a suspension of compound 7 (100 mg, 0.27 mmol) and compound 16 (89 mg, 0.27 mmol) in CH 2 Cl 2 (3 ml) at 0°C. The reaction mixture was stirred for 1 h at ambient temperature. Then NaBH(OAc) 3 (114 mg, 0.54 mmol) was added to the reaction mixture at 0°C, and the reaction mixture was stirred at ambient temperature overnight. Then the reaction mixture was made basic with 1 N aqueous NaOH to pH 8, and was extracted with CHCl 3 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 Cl 2 : MeOHϭ20 : 1-5 : 1) to give compound 17 (43 mg, 30% 
4-[(6-Chloro-2-naphthalenyl)sulfonyl]-1-[[4-(hydroxyiminomethyl)-1-(4-pyridinyl)-4-piperidinyl]methyl]piperazinone (18)
The solution of DMSO (99 ml) in CH 2 Cl 2 (4.5 ml) was added to the solution of oxalyl chloride (61 ml) in CH 2 Cl 2 (4.5 ml) below Ϫ70°C. The solution of compound 17 (185 mg, 0.35 mmol) in DMSO-CH 2 Cl 2 (2.2-2.2 ml) was added to the above solution below Ϫ70°C. The reaction mixture was stirred for 1 h between Ϫ60 and Ϫ65°C. Then Et 3 N (292 ml, 2.1 mmol) was added to the reaction mixture at Ϫ78°C. After the temperature was raised to room temperature, water was added to the reaction mixture. The reaction mixture was extracted with CH 2 Cl 2 , washed with brine and dried over Na 2 SO 4 . The solvent was removed under reduced pressure. Without purification, the residue was dissolved in EtOH-CHCl 3 (6-1.2ml). Then sodium acetate (48 mg, 0.6 mmol) and hydroxylamine hydrochloride (38 mg, 0.6 mmol) were added to the reaction mixture. The reaction mixture was stirred at ambient temperature overnight. Water was added to the reaction mixture, and this mixture was made basic with saturated NaHCO 3 aq. to pH 8, then extracted with CHCl 3 . The organic layer was washed with water and brine, dried over Na 2 SO 4 24 (2H, m) .
4-[4-[(6-Chloro-2-naphthalenyl)sulfonyl]-6-oxopiperazinyl]methyl-1-(4-pyridinyl)-4-piperidinecaboxylic Acid (19)
A solution of DMSO (23 ml) in CH 2 Cl 2 (1.0 ml) was added to the solution of oxalyl chloride (14 ml) in CH 2 Cl 2 (1.0 ml) below Ϫ70°C. A solution of compound 17 (37 mg, 0.35 mmol) in DMSO-CH 2 Cl 2 (0.4-0.4 ml) was added to the above solution below Ϫ70°C. The reaction mixture was stirred for 1 h between Ϫ60 and Ϫ65°C. Then Et 3 N (60 ml, 0.4 mmol) was added to the reaction mixture at Ϫ78°C. After the temperature was raised to room temperature, water was added to the reaction mixture. This reaction mixture was extracted with CH 2 Cl 2 and washed with brine, then dried over Na 2 SO 4 . The solvent was removed under reduced pressure. Without purification, 2-methyl-2-butene (56 ml, 0.5 mmol) was added to the solution of the residue in tert-butanol-CHCl 3 (0.5-0.1 ml). Then the solution of NaClO 2 (11.7 mg, 0.1 mmol) and NaH 2 PO 4 -2H 2 O (16.1 mg, 0.1 mmol) in water (0.4 ml) was added to the solution. The reaction mixture was vigorously stirred at ambient temperature overnight. Saturated NH 4 Cl aq. was added to reaction mixture. Then CHCl 3 and MeOH were added to the reaction mixture, successively. Na 2 SO 4 was added to the reaction mixture, and the solvent was evaporated under reduced pressure. The residue was triturated with THF to give compound 19 (40 mg, 93%) as a white powder. 
4-[4-[(6-Chloro-2-naphthalenyl)sulfonyl]-6-oxopiperazinyl]methyl-1-(4-pyridinyl)-4-piperidinecaboxylic Acid Methyl Ester (20)
To the solution of compound 19 (10 mg, 0.02 mmol) in MeOH-CH 2 Cl 2 (0.5-0.5 ml), trimethylsilyldiazomethane (12 ml, 0.02 mmol; 2.0 M in n-hexane) was added at 0°C. The reaction mixture was stirred at ambient temperature for 2 h. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 
1-(4-Pyridinyl)-4-piperidinecarboxaldehyde (22)
A solution of oxalyl chloride (1.77 ml, 20 mmol) in CH 2 Cl 2 (85 ml) was cooled to Ϫ78°C under Ar. To the cooled solution, a solution of DMSO (3.25 ml, 42 mmol) in dry CH 2 Cl 2 (85 ml) was added dropwise for 20 min. Then, a solution of compound 21 (3.0 g, 15.6 mmol) prepared by a documented method 35) in dry CH 2 Cl 2 (48 ml) and dry DMSO (48 ml) was added dropwise for another 20 min. The reaction mixture was stirred at between Ϫ65°C and Ϫ60°C for 1 h, then cooled to Ϫ78°C, and Et 3 N (8.31 ml, 60 mmol) was added. The reaction mixture was allowed to stand at room temperature, water (200 ml) was added, and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The resulting aldehyde 22 was rather unstable and should be used in the next reaction without purification. MS m/z: 
3-(tert-Butoxycarbonylamino)-N-[[1-(4-pyridinyl)-4-piperidinyl]-methyl]alanine Ethyl Ester (23)
Crude product 22 (0.56 g, 2.9 mmol), obtained by Swern oxidation, was suspended in dry CH 2 Cl 2 (16 ml). To the suspension, b-(tert-butoxycarbonylamino)-alanine ethyl ester (0.70 g, 3.0 mmol) obtained by a documented method 36) and AcOH (0.37 ml) were added in that order. After stirring the resulting mixture at room temperature for 30 min under Ar, NaBH(OAc) 3 (1.6 g, 7.5 mmol) was added and the reaction mixture was stirred overnight at room temperature. Water (20 ml) was added to the reaction mixture, then it was adjusted to pH 9 with 1 N sodium hydroxide solution, followed by extraction with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated at reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 3 N (1.2 ml, 8.4 mmol) were added in that order, and the mixture was stirred at Ϫ78°C for 1 h. The reaction mixture was allowed to stand at room temperature for 5 h. After cooling the reaction mixture with ice, water was added, and it was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. To the solution of residue (5.1 g) in EtOH (38 ml), 20 wt% HCl-EtOH (38 ml) was added at 0°C for 5 min and stirred at 0°C. The mixture was allowed to stand at room temperature with stirring for 2 h. The solvent was evaporated under reduced pressure and the residue was used in the next reaction without purification. A solution of the residue in anhydrous dimethylformamide (DMF) (6.7 ml) was cooled with ice. To the cooled solution, Et 3 N (14.8 ml, 0.11 mol) was added, and the mixture was stirred at room temperature for 3 h. The reaction mixture was concentrated under reduced pressure. 
4-[(6-Chloro-2-naphthalenyl)sulfonyl]-6-oxo-1-[[1-(4-pyridinyl)-4-piperidinyl]methyl]-2-piperazinecarboxylic Acid Ethyl Ester (25)
Compound 24 (52 mg, 0.15 mmol) was dissolved in CH 2 Cl 2 (5 ml). To the solution, Et 3 N (0.1 ml, 0.7 mmol) and 6-chloro-2-naphthalenesulfonyl chloride (39.1 mg, 0.15 mmol) were added, in that order, and the mixture was stirred overnight at room temperature. Water was added to the reaction mixture, which was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 
4-[(6-Chloro-2-naphthalenyl)sulfonyl]-6-oxo-1-[[1-(4-pyridinyl)-4-piperidinyl]methyl]-2-piperazinecarboxylic Acid (26)
To a solution of the compound 25 (18 mg, 0.03 mmol) in MeOH (0.5 ml), 2 N NaOH solution (63 ml) was added, and the mixture was stirred at 40°C for 30 min. The reaction mixture was concentrated under reduced pressure and the resulting residue was dissolved in water and rendered weakly acidic with 0.1 N HCl. The supernatant was removed by decantation, and the residue was dissolved in MeOH, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure to give compound 26 (9 mg, 53%). 44 (1H, m), 8.14-8.00 (5H, m) , 7.85 (1H, dd, Jϭ2, 9 Hz), 7.65 (1H, dd, Jϭ2, 9 Hz), 6.72 (2H, d, Jϭ6 Hz), 4.19 (1H, t, Jϭ3 Hz),   4.13-4.04 (2H, m), 3.96-3.80 (3H, m), 3.55 (1H, d, Jϭ17 Hz) 10 (2H, m) .
4-[(6-Chloro-2-naphthalenyl)sulfonyl]-6-(hydroxymethyl)-1-[[1-(4-pyridinyl)-4-piperidinyl]methyl]piperazinone (28)
Compound 25 (0.15 g, 0.26 mmol) was dissolved in MeOH (10 ml). To the solution, lithium borohydride (0.60 g, 27.5 mmol) was added in three portions at 30-min intervals. To the reaction mixture, 10% HCl-MeOH was added under cooling with ice to make it acidic, and the mixture was then concentrated to dryness. Water was added to the residue, then saturated NaHCO 3 aq. was added to make the residue alkaline, and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with brine, dried over Na 2 SO 4 (1 ml) . To the stirred suspension, 50% NaOH solution (0.3 ml) was added under cooling with ice. Then, benzyltriethylammonium chloride (3 mg, 0.013 mmol) and dimethyl sulfate (9 ml, 0.09 mmol) were added, and the mixture was stirred for 2 h under cooling with ice. Ice water was added to the reaction mixture to quench the reaction, and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluents; CH 2 was suspended in EtOH (15 ml). Hydrazine monohydrate (54 ml, 1.11 mmol) was added to the suspension at room temperature, followed by stirring at room temperature for 20 h. The suspension was then allowed to reflux for 4 h. After leaving the suspension to cool, the insolubles were filtered off and the filtrate was concentrated. The residue was purified by silica gel column chromatography (eluents; CH 2 2 Cl 2 (1 ml) was cooled to Ϫ78°C under Ar. To the cooled solution, a solution of DMSO (60 ml, 0.76 mmol) in CH 2 Cl 2 (1 ml) was added dropwise over 20 min. Then, a solution of compound 28 (10 mg, 0.019 mmol) in CH 2 Cl 2 (1 ml) was added dropwise over another 20 min. The reaction mixture was stirred at between Ϫ65°C and Ϫ60°C for 1 h, the mixture was cooled to Ϫ78°C, and Et 3 N (0.16 ml, 1.14 mmol) was added. The reaction mixture was allowed to stand at room temperature, water (4 ml) was added, and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The resulting crude aldehyde was dissolved in EtOH (1 ml). Hydroxylamine hydrochloride (2.5 mg, 0.038 mmol) and sodium acetate (3 mg, 0.038 mmol) were added to the solution. AcOH was added to the reaction mixture to adjust its pH to about 4, then the mixture was stirred overnight at room temperature. The reaction mixture was rendered alkaline by the addition of saturated NaHCO 3 aq., then extracted with CH 2 Cl 2 . The organic layer was washed with brine, dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography [ 3 mmol) in 1 N HCl (300 ml) was heated under reflux for 11 h. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in MeOH (60 ml), and 1 N aqueous NaOH was added to make it alkaline. To the solution, Muromac TM MSC-1 (H ϩ form, 60 g, Muromachi Kagaku Kogyo Kaisha, Ltd.) was added, and the resulting suspension was stirred at room temperature for 30 min. The ion exchange resin was collected with suction, then washed with water and MeOH. To the resin, 10% (w/w) NH 3 -MeOH (150 ml) was added. After stirring for 30 min, the resin was filtered off and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (Chromatorex NH TM (Fuji Silysia Chemical, Ltd.) eluents; AcOEt : MeOHϭ3 : 1-1 : 2) to give (R)-4-[(6-chloro-2-naphthalenyl)sulfonyl]-6-oxo-1-[[1-(4-pyridinyl)-4-piperidinyl]methyl]-2-piperazinecarboxylic acid ammonium salt (2.22 g, 75%). To a solution of the ammonium salt (300 mg, 0.54 mmol), 0.1 M H 2 SO 4 aq. (2.7 ml) was added, and the resulting precipitate was collected to give compound 34 (258 mg, 86% 01 (1H, m), 2.81-2.67 (2H, m), 2.60-2.47 (1H, m), 1.89-1.73 (1H, m) HCl (5 ml) was heated under reflux for 12 h. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in MeOH (5 ml), and 1 N aqueous NaOH was added to make it alkaline. To the solution, Muromac TM MSC-1 (H ϩ form, 1 g, Muromachi Kagaku Kogyo Kaisha, Ltd.) was added, and the resulting suspension was stirred at room temperature for 30 min. The ion exchange resin was collected with suction, then washed with water and MeOH. To the resin, 10% (w/w) NH 3 -MeOH (5 ml) was added. After stirring for 30 min, the resin was filtered off and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (Chromatorex NH  TM 
